The short answer: it does not stabilise

The question most patients bring to their first consultation is some version of the same thing: if I leave it alone, will it settle down? For hip articular cartilage, the honest answer is no — and the reason is anatomical rather than probabilistic.

Cartilage covering the femoral head and acetabulum has no blood supply. It receives oxygen and nutrients through the synovial fluid that bathes it during movement, not through vessels that could carry repair cells to a damaged site. Once a focal defect forms, no healing process arrives to fill it. That is not a worst-case scenario; it is how cartilage is built.

What happens next follows from mechanics. The defect edge concentrates abnormal shear stress on the surrounding cartilage rim, which gradually breaks down, widening the lesion. As the surface erodes, subchondral bone is exposed, creating bone-on-bone contact, marrow oedema, and cyst formation — changes that are very difficult to reverse. Orthopaedic literature consistently describes the end point of this untreated pathway as diffuse hip osteoarthritis and, ultimately, total hip replacement.

How quickly this unfolds varies between individuals, and a controlled long-term natural-history study specific to the hip does not yet exist. Timelines to osteoarthritis onset are inferred from structural studies rather than directly measured — a genuine gap in the evidence, not a source of reassurance.

Why the damage keeps spreading: the mechanical cycle

Picture a pothole in a road surface. Traffic does not avoid it — wheels drop into the gap, stressing the tarmac at the edge until the rim crumbles and the hole widens. A focal cartilage defect behaves the same way. During ordinary walking and stair-climbing, load that healthy cartilage would distribute evenly instead concentrates at the defect rim. That rim degrades under repeated stress, the lesion grows, and more rim becomes exposed — a self-reinforcing cycle that normal daily activity sustains without any additional injury.

As the articular surface retreats, the subchondral bone beneath it comes into direct contact with the opposing joint surface. Bone-on-bone friction drives marrow oedema and, over time, subchondral cyst formation — structural changes that represent a deeper tier of joint damage than cartilage loss alone.

Meanwhile, fragments of cartilage detach from the defect margin and migrate freely through the joint as loose bodies. These produce the mechanical symptoms — catching, locking, or giving way — that patients often describe as the moment they realised something was seriously wrong.

A further mechanism may compound the cycle. A 2026 biomechanical study of 121 active footballers found that those with more severe cartilage defects walked with significantly lower hip contact force impulse than those with no defects. Cartilage depends partly on cyclical mechanical loading for nutrient exchange through synovial fluid, so pain-driven under-loading risks starving the remaining cartilage of the stimulation it needs — potentially accelerating the very degeneration the patient is unconsciously trying to protect against.

What speeds up progression

Several factors determine whether a focal defect smoulders quietly or deteriorates rapidly — and understanding them is the difference between watchful waiting and acting before the window for joint preservation closes.

Defect grade and size

Not all cartilage defects carry the same urgency. Full-thickness lesions — ICRS or Outerbridge grades III–IV, where damage reaches or penetrates the subchondral bone — progress faster than partial-thickness injuries, and defects larger than 2 cm² are associated with the highest risk of rapid deterioration. These two variables are the strongest predictors of how quickly the cycle described in the previous section will accelerate.

Structural comorbidities: FAI and dysplasia

A focal defect in an otherwise normal hip is concerning. The same defect in a hip with femoroacetabular impingement (FAI) is considerably more so. FAI generates repetitive mechanical impingement with every movement of the joint — the bony abnormality effectively continues to grind against the cartilage even if the focal lesion itself were otherwise contained. The clinical consequence, if left unaddressed, is a cascade: labral degeneration, accelerating cartilage loss, and early-onset osteoarthritis.

Borderline hip dysplasia presents a subtler but equally important risk. Micro-instability in these hips can drive osteochondral defects at the anterolateral femoral head that appear benign on standard imaging. A 2024 study describing the 'Windshield Wiper Sign' demonstrated that these instability-related defects are detectable on plain radiograph and MRI, but identifying them requires specialist assessment to plan combined cartilage and bony correction — a standard referral cannot be expected to catch this pattern.

The narrowing repair window

Once the labrum and capsule are compromised, the biological conditions for cartilage repair deteriorate significantly. A 2025 animal-model study found that microfracture performed in hips where stability was already lost produced markedly inferior cartilage regeneration — lower type II collagen and aggrecan expression — compared with hips where the labrum was preserved and the capsule repaired. The implication for patients is direct: the longer structural integrity is allowed to erode, the narrower the range of repair options available. Focal defects and structural abnormalities cannot be assessed or treated as separate problems.

Symptoms that should prompt specialist review

Knowing when to move beyond GP management and seek specialist assessment comes down to recognising a specific pattern of symptoms — ones that reflect structural mechanical pathology rather than generalised joint ache.

The following warrant prompt specialist review:

• Mechanical locking or catching — a sensation of the joint briefly jamming or clicking through range of motion. As noted earlier, these symptoms point to loose bodies moving within the joint and will not resolve with rest or physiotherapy alone.
• Giving way — an unexpected sense that the hip is about to buckle under load. This is distinct from muscle weakness secondary to pain-inhibition; true giving way suggests the joint is mechanically unreliable and requires structural assessment.
• Deep groin pain that worsens with hip rotation or full flexion — the classic impingement arc of FAI. When this positional pain accompanies either of the above, urgency increases considerably, as it suggests an active structural driver rather than isolated tissue irritation.
• Night pain or pain at rest — background ache during activity is one thing; pain that disturbs sleep or persists when the hip is completely unloaded is associated with subchondral involvement and a more advanced stage of deterioration.

One important caveat: intermittent symptoms do not indicate a stable defect. Loose bodies shift position within the joint, producing periods of relative quiet between episodes. A symptom-free week after a locking episode does not mean the underlying cartilage damage has resolved — it means the loose body has temporarily moved out of the impingement zone. Structural damage accumulates in both symptomatic and asymptomatic intervals.

What specialist assessment involves

Assessment begins not with a scan but with a structured clinical history — mapping symptom onset, pattern, provocative activities, and functional impact before any imaging is ordered. Hip rotation, the impingement arc, and functional range of motion are then assessed by hand; the physical examination captures how the joint responds to specific provocative tests and where pain is reproduced in the movement arc, information that no scanner alone provides.

Imaging follows to grade the defect and characterise the surrounding anatomy. MRI with intra-articular contrast — an MR arthrogram — is the primary tool. Contrast medium injected into the joint distends the capsule, improving resolution of cartilage depth, labral integrity, and capsular status beyond what a standard MRI achieves. The report directs planning but does not replace clinical judgement; a scan showing a focal defect cannot on its own define what intervention is appropriate or whether structural correction is also needed.

That structural question is central to the whole workup. Grade III–IV lesions, defects exceeding 2 cm², and any focal defect coexisting with FAI or dysplasia require combined structural planning — the cartilage problem and the mechanical cause driving it cannot be assessed as separate workstreams. Missing the structural diagnosis at this stage leads to treatment of the lesion without addressing the conditions that produced it.

The aim of this assessment is to establish what options remain open. Earlier referral preserves more of them; advanced degeneration narrows them toward replacement rather than repair. Patients with confirmed structural abnormality alongside a focal defect are best served by a surgeon experienced in both cartilage repair and hip-preservation procedures, positioned to map the full clinical picture and advise on timing rather than treating each finding in isolation.

The treatment pathway and the cost of delay

The treatment pathway runs in four broad stages, and the critical variable is where a patient enters it.

Conservative measures — activity modification, physiotherapy, and load management — can reduce symptoms and improve daily function. They do not reverse cartilage loss or correct any underlying structural abnormality. For many patients this stage is a reasonable starting point; it is not a long-term substitute for structural assessment when a defect is confirmed.

Biologic and injection therapies can support the joint environment and reduce inflammatory burden, but similarly do not restore lost cartilage tissue. Their role is contextual — useful within a managed pathway, not as a standalone response to a structural problem.

Joint-preservation procedures represent the strongest argument for early referral. Husen et al. (2023), in a long-term follow-up study subsequently cited 51 times, found evidence for a preventive effect of hip arthroscopy on osteoarthritis development and progression in young FAI patients — a direct demonstration that timely intervention changes trajectory, not merely symptoms. Advanced cartilage repair, including biologic augmentation, has achieved clinically meaningful outcomes even in grade IV chondromalacia; in one published series, 89.3% of patients reached the minimal clinically important difference at two years. Even so, 10.9% of that cohort converted to total hip replacement within approximately 31 months — a reminder that grade IV disease carries significant risk even when actively treated.

Total hip replacement is a reliable endpoint, but it represents the closure of the preservation window. The practical referral threshold — grade III–IV defect, lesion exceeding 2 cm², mechanical symptoms, or a structural comorbidity such as FAI or dysplasia — exists because acting within that window is what keeps replacement a distant outcome rather than an imminent one. Earlier specialist assessment preserves more options; delay compresses them steadily toward the replacement end.

1. [1] Preserving Hip Stability Yields Better Cartilage Repair With Microfracture Treatment (2025). (2025). https://doi.org/10.1016/j.asmr.2025.101284 https://doi.org/10.1016/j.asmr.2025.101284
2. [2] The Hip 'Windshield Wiper Sign': Osteochondral Defect of the Anterolateral Femoral Head, Predicts Instability (2024). (2024). https://doi.org/10.1016/j.arthro.2024.06.003 https://doi.org/10.1016/j.arthro.2024.06.003